GSK · Categories · Downgrades
GSK - Analyst downgrades
GSK plc (GSK) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for GSK
- GlaxoSmithKline downgraded by BarclaysBarclays downgraded GlaxoSmithKline from Equal Weight to Underweight
- GlaxoSmithKline downgraded by BerenbergBerenberg downgraded GlaxoSmithKline from Buy to Hold
- GlaxoSmithKline downgraded by Deutsche BankDeutsche Bank downgraded GlaxoSmithKline from Buy to Hold
- GlaxoSmithKline downgraded by Jefferies with a new price targetJefferies downgraded GlaxoSmithKline from Buy to Hold and set a new price target of $39.50 from $53.00 previously
- GlaxoSmithKline downgraded by GuggenheimGuggenheim downgraded GlaxoSmithKline from Buy to Neutral
- GlaxoSmithKline downgraded by UBSUBS downgraded GlaxoSmithKline from Buy to Neutral
- GlaxoSmithKline downgraded by JP MorganJP Morgan downgraded GlaxoSmithKline from Neutral to Underweight
- GlaxoSmithKline downgraded by BofA SecuritiesBofA Securities downgraded GlaxoSmithKline from Neutral to Underperform
- GlaxoSmithKline downgraded by UBSUBS downgraded GlaxoSmithKline from Neutral to Sell
- GlaxoSmithKline downgraded by Jefferies with a new price targetJefferies downgraded GlaxoSmithKline from Buy to Hold and set a new price target of $34.00 from $50.50 previously
- GlaxoSmithKline downgraded by DZ BankDZ Bank downgraded GlaxoSmithKline from Buy to Hold
- GlaxoSmithKline downgraded by SVB LeerinkSVB Leerink downgraded GlaxoSmithKline from Outperform to Mkt Perform
- GlaxoSmithKline downgraded by Deutsche BankDeutsche Bank downgraded GlaxoSmithKline from Hold to Sell
- GlaxoSmithKline downgraded by Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft downgraded GlaxoSmithKline from Hold to Sell